Skip to main content
Xlife Sciences AG logo

Xlife Sciences AG — Investor Relations & Filings

Ticker · XLS ISIN · CH0461929603 LEI · 984500AH590BE88BB517 SW Professional, scientific and technical activities
Open in API
Filings indexed 287 across all filing types
Latest filing 2022-09-28 Earnings Release
Country CH Switzerland
Listing SW XLS

About Xlife Sciences AG

https://www.xlifesciences.ch/en/home

Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.

Recent filings

Filing Released Lang Actions
Xlife Sciences mit erfreulichen Fortschritten im 1. Halbjahr 2022
Earnings Release Classification · 1% confidence The document is titled 'Ad hoc-Mitteilung gemäss Art. 53 KR' (Ad hoc announcement according to Art. 53 KR) and explicitly states that Xlife Sciences AG has 'heute die Ergebnisse für das per 30. Juni 2022 endende erste Halbjahr 2022 veröffentlicht' (today published the results for the first half-year ending June 30, 2022). It provides key financial figures (Umsatzerlös, Ergebnis je Aktie, Bilanzsumme) and operational highlights for the first half of the year. This content structure—a summary announcement of period-specific financial results that is not the full, detailed report—aligns perfectly with the definition of an Earnings Release (ER). Although it covers a half-year period, the format is a brief press release announcing the results, not the comprehensive 'Interim/Quarterly Report' (IR) itself, especially since it directs the reader to the company website for the 'vollständige Halbjahresbericht 2022' (full half-year report 2022). Therefore, it is classified as an Earnings Release (ER). H1 2022
2022-09-28 German
Project company Laxxon Medical achieves major milestone
Environmental & Social Information Classification · 1% confidence The document is a press release from Xlife Sciences AG announcing a major milestone for its project company, Laxxon Medical, specifically the granting of a U.S. Patent. It contains news details, corporate information, contact details, and a financial calendar. It is not a formal regulatory filing like a 10-K, nor is it a transcript (CT), an earnings release (ER), or a specific financial report (IR, AR). Since it is a general corporate announcement of a significant, non-financial event (patent grant) and does not fit into the specific categories like M&A (TAR) or Director's Dealing (DIRS), it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings), as it is a news release disseminated to the market. The document length is relatively short (under 5,000 characters) and it is a direct announcement, not an announcement *about* another report, so RPA is not the best fit.
2022-09-26 English
Project company Laxxon Medical achieves major milestone
Report Publication Announcement Classification · 1% confidence The document is a press release dated 26.09.2022 announcing a major milestone for a project company (Laxxon Medical) regarding a granted U.S. Patent. It contains company updates, executive commentary, and a financial calendar mentioning the upcoming 'Semi-Annual Report 2022'. The content is an announcement of a specific event (patent grant) rather than a comprehensive financial report (like 10-K or IR) or a transcript. Since it is a general corporate announcement that doesn't fit the specific categories like DIV, DIRS, or MANG, and it is not explicitly an announcement of a report publication (RPA), the most appropriate general category for significant corporate news that isn't a standard financial filing is Regulatory Filings (RNS), which serves as a broad category for miscellaneous regulatory announcements, especially those originating from non-US exchanges or general corporate news wires.
2022-09-26 English
Projektgesellschaft Laxxon Medical erreicht wichtigen Meilenstein
Regulatory Filings Classification · 1% confidence The document is a press release titled 'Xlife Sciences AG / Schlagwort(e): Sonstiges' announcing that its project company, Laxxon Medical, achieved a significant milestone by receiving a US Patent (US Patent 11,419,824 B2) for controlled drug delivery systems. It also includes a financial calendar entry mentioning the 'Halbjahresbericht 2022' (Half-Year Report 2022) released on September 28, 2022, which suggests this announcement precedes or coincides with the release of an interim report, but the content itself is a specific operational/IP update, not the full financial report (IR) or the earnings release (ER). This type of announcement, focusing on a specific operational achievement (patent grant) and framed as a 'Medienmitteilung' (Media Release), does not fit the definitions for 10-K, AR, ER, IR, or CT. It is not a management change (MANG), director dealing (DIRS), or dividend notice (DIV). Since it details a significant development related to intellectual property and technology platforms, it is best classified as a general Regulatory Filing (RNS) or potentially a specific operational update. Given the options, and since it is a general news release about a corporate development that doesn't fit the highly specific financial/governance categories, RNS (Regulatory Filings / miscellaneous announcements) is the most appropriate fallback, although it could also be argued as an Investor Presentation (IP) if it were more strategic, but it reads like a standard news bulletin. However, upon reviewing the definitions, this is a standard corporate news release announcing a major operational/IP event. It is not a formal regulatory filing like a 10-K or a specific financial report. Since it is a general announcement that doesn't fit the other specific categories (like MANG, DIV, CAP, etc.), the fallback category 'RNS' (Regulatory Filings / miscellaneous announcements) is the most suitable classification for a general press release of this nature.
2022-09-26 German
Xlife Sciences strengthens sustainability activities with ESG strategy
Environmental & Social Information Classification · 1% confidence The document is a press release dated September 21, 2022, announcing that Xlife Sciences is strengthening its sustainability activities by developing and adopting an ESG strategy. It details the focus areas, KPIs, and states that the annual ESG reporting will commence with the Annual Report 2022. This content directly relates to the company's performance on Environmental, Social, and Governance (ESG) factors. According to the definitions, this aligns perfectly with the Environmental & Social Information category (Code: SR). It is not a full 10-K, an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2022-09-21 English
Xlife Sciences strengthens sustainability activities with ESG strategy
Environmental & Social Information Classification · 1% confidence The document is a press release dated 21.09.2022 announcing that Xlife Sciences AG has developed an ESG strategy and will begin annual ESG reporting starting with the Annual Report 2022. The content focuses entirely on the company's environmental, social, and governance initiatives, objectives, and reporting plans. This directly aligns with the definition of Environmental & Social Information (ESG Report content). Although it mentions the ESG reporting will be included in the Annual Report 2022, the document itself is the announcement of the strategy and the intent to report, not the full Annual Report (10-K) or the ESG report itself. Since the core subject matter is ESG performance and reporting structure, the most appropriate classification is 'Environmental & Social Information' (SR). It is not a generic regulatory filing (RNS) because a specific category exists.
2022-09-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.